Australia Recognises Covaxin For Travel As It Eases Border Curbs

This will have a significant impact on the return of international students, and the travel of skilled and unskilled workers to Australia.

Australia today recognised India's Covaxin for the purpose of travel to the country as it eased curbs on international travel. After more than 18 months of some of the world's strictest Coronavirus border policies, millions of Australians are now free to travel without a permit or the need to quarantine on arrival in the country. Today, the TGA determined that Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognised' for the purpose of establishing a traveller's vaccination status.Read more: https://t.co/fpQvr7FQhWpic.twitter.com/YLqIAglMQX

"Covaxin (manufactured by Bharat Biotech, India) and BBIBP-CorV (manufactured by Sinopharm, China) vaccines would be 'recognised' for the purpose of establishing a traveller's vaccination status. This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV," a media release from the Australian government said.

Earlier, the Therapeutic Goods Administration (TGA), Australia's regulatory authority for therapeutic goods, had recommended that only the vaccines approved for use in Australia, and Covishield from India and Sinovac from China be recognised for the purposes of travel and other restrictions.